Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11993909
[patent_doc_number] => 20170298063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/514407
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22371
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/514407 | Compounds a | Sep 21, 2015 | Issued |
Array
(
[id] => 11935093
[patent_doc_number] => 20170239242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/512872
[patent_app_country] => US
[patent_app_date] => 2015-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17721
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512872 | Methods and pharmaceutical compositions for the treatment of fibrosis | Sep 20, 2015 | Issued |
Array
(
[id] => 11991632
[patent_doc_number] => 20170295788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'USE OF HETEROCYCLIC FLUOROALKENYL SULFONE COMPOUNDS FOR REPELLING MOLLUSCS'
[patent_app_type] => utility
[patent_app_number] => 15/511660
[patent_app_country] => US
[patent_app_date] => 2015-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3869
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511660 | USE OF HETEROCYCLIC FLUOROALKENYL SULFONE COMPOUNDS FOR REPELLING MOLLUSCS | Sep 16, 2015 | Abandoned |
Array
(
[id] => 10729515
[patent_doc_number] => 20160075663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS'
[patent_app_type] => utility
[patent_app_number] => 14/853815
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27058
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853815
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/853815 | Benzoimidazol-1,2-yl amides as Kv7 channel activators | Sep 13, 2015 | Issued |
Array
(
[id] => 11887965
[patent_doc_number] => 09758517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Histone demethylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/852860
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19719
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852860
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/852860 | Histone demethylase inhibitors | Sep 13, 2015 | Issued |
Array
(
[id] => 10489647
[patent_doc_number] => 20150374668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/849190
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25610
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/849190 | CHEMICAL COMPOUNDS | Sep 8, 2015 | Abandoned |
Array
(
[id] => 10729563
[patent_doc_number] => 20160075711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE'
[patent_app_type] => utility
[patent_app_number] => 14/845428
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94674
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14845428
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/845428 | Compounds for the inhibition of indoleamine-2,3-dioxygenase | Sep 3, 2015 | Issued |
Array
(
[id] => 10714114
[patent_doc_number] => 20160060260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'BROMODOMAIN INHIBITORS FOR TREATING DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/838570
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39941
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838570
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838570 | BROMODOMAIN INHIBITORS FOR TREATING DISEASE | Aug 27, 2015 | Abandoned |
Array
(
[id] => 10481760
[patent_doc_number] => 20150366776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/838381
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 35711
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838381
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838381 | Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof | Aug 27, 2015 | Issued |
Array
(
[id] => 10476015
[patent_doc_number] => 20150361032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'BENZIMIDAZOLE INHIBITORS OF THE SODIUM CHANNEL'
[patent_app_type] => utility
[patent_app_number] => 14/833601
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29925
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833601
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833601 | Benzimidazole inhibitors of the sodium channel | Aug 23, 2015 | Issued |
Array
(
[id] => 16125893
[patent_doc_number] => 10696687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Pyrazolo fused heterocyclic compounds as ERK inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/753008
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20021
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 820
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753008
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753008 | Pyrazolo fused heterocyclic compounds as ERK inhibitors | Aug 19, 2015 | Issued |
Array
(
[id] => 13196059
[patent_doc_number] => 10112939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Tied-back benzamide derivatives as potent rock inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/503419
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29433
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503419 | Tied-back benzamide derivatives as potent rock inhibitors | Aug 19, 2015 | Issued |
Array
(
[id] => 10459405
[patent_doc_number] => 20150344420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'PACLITAXEL ENHANCER COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/826889
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 13910
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826889
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/826889 | PACLITAXEL ENHANCER COMPOUNDS | Aug 13, 2015 | Abandoned |
Array
(
[id] => 10459473
[patent_doc_number] => 20150344488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'SOLID FORMS OF AN ANTIVIRAL COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/825386
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23170
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/825386 | Solid forms of an antiviral compound | Aug 12, 2015 | Issued |
Array
(
[id] => 15512565
[patent_doc_number] => 10562858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Crystalline anti-trichophyton agents and preparation process thereof
[patent_app_type] => utility
[patent_app_number] => 15/503094
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8660
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503094 | Crystalline anti-trichophyton agents and preparation process thereof | Aug 11, 2015 | Issued |
Array
(
[id] => 11446504
[patent_doc_number] => 20170047525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'BENZOTRIIMIDAZOLE MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 14/822918
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4431
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14822918
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/822918 | BENZOTRIIMIDAZOLE MATERIALS | Aug 10, 2015 | Abandoned |
Array
(
[id] => 11849468
[patent_doc_number] => 20170223960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'NOVEL HALOGEN-SUBSTITUTED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/501733
[patent_app_country] => US
[patent_app_date] => 2015-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59798
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501733
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501733 | Halogen-substituted compounds | Aug 4, 2015 | Issued |
Array
(
[id] => 11757221
[patent_doc_number] => 20170204089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'NOVEL COMPOUNDS AND METHODS OF TREATING OR AMELIORATING AN IL-1R-MEDIATED DISEASE OR DISORDER USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/328281
[patent_app_country] => US
[patent_app_date] => 2015-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18023
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328281 | NOVEL COMPOUNDS AND METHODS OF TREATING OR AMELIORATING AN IL-1R-MEDIATED DISEASE OR DISORDER USING SAME | Aug 2, 2015 | Abandoned |
Array
(
[id] => 11836229
[patent_doc_number] => 20170217948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'XANTHINE OXIDASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/329695
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25023
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329695 | XANTHINE OXIDASE INHIBITOR | Jul 28, 2015 | Abandoned |
Array
(
[id] => 11429001
[patent_doc_number] => 09567309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Desferrithiocin polyether analogues'
[patent_app_type] => utility
[patent_app_number] => 14/811598
[patent_app_country] => US
[patent_app_date] => 2015-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8468
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14811598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/811598 | Desferrithiocin polyether analogues | Jul 27, 2015 | Issued |